Biotechnology Stocks II Performance Guide: Marinus Pharmaceuticals, Inc. (MRNS)
MRNS has no dividends.
Table and Chart of MRNS Performance
See what a $1,000 investment in MRNS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MRNS Returns | |
|---|---|
| Start Date | Aug-29-2014 |
| Start Price | $32.08 |
| End Date | Jul-26-2024 |
| End Price | $1.43 |
| # Prices | 120 |
| Min Date | Jun-28-2024 |
| Min Price | $1.17 |
| Max Date | Jul-31-2015 |
| Max Price | $65.96 |
| Total Return | -95.54% |
| Annualized Return | -26.73% |
| Current Value of $1,000 Purchase | $45 |
| Number Returns | 7,140 |
| Average Return | -9.49% |
| Number Profitable Returns | 2,110 |
| Percent Profitable Returns | 29.55% |
| Number Unprofitable Returns | 5,030 |
| Percent Unprofitable Returns | 70.45% |
| Profitable to Unprofitable Returns Ratio | 0.42 |
| MRNS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $77,731,000 |
| Beta | 1.125 | Price to Sales | 13.33 |
| Earnings per Share | $-2.6400 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 24.57 |
| PRICE DATA | |
| 52 Week High | $11.26 |
| 52 Week Low | $1.1 |
| Analyst Target Price | $6.9 |
| 50-Day Moving Average | $1.379 |
| 200-Day Moving Average | $6.04 |
| FINANCIAL DATA | |
| Revenue per Share | $0.514 |
| Revenue | $28,288,000 |
| Profit Margin | 0% |
| Return on Equity | -423.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MRNS Compare Returns with S&P 500
MRNS Trendline Chart
MRNS Moving Average Chart
MRNS Stock Return Map - See Patterns of Gains and Losses
MRNS Stock Returns/Purchase Dates